Logo
Logo


ISSN: 0300-9041
ISSNe: 2594-2034


Indizada en: SciELO, Índice Médico Latinoamericano, LILACS, Medline
Editada por la Federación Mexicana de Colegios de Obstetricia, y Ginecologia AC
Fundada por la Asociación Mexicana de Ginecología y Obstetricia en 1945
 

INFORMACIÓN EXCLUSIVA PARA LOS PROFESIONALES DE LA SALUD


Periodicidad: continua
Abreviatura: Ginecol Obstet Mex
ISSN: 0300-9041
ISSNe: 2594-2034
Indizada en: Scimago, Índice Médico Latinoamericano, Lilacs, Medline, Science Citation Index, Ulrich, Ebsco.

¿Fertilización in vitro o conversión a inseminación intrauterina en baja reserva? Revisión sistemática y metanálisis

Intrauterine insemination versus in vitro fertilization in poor responders: a systematic review and meta-analysis.

Ginecol Obstet Mex. 2021; 89 (3): 232-246.

https://doi.org/10.24245/gom.v89i3.4827

Jorge Rodríguez-Purata,1,2 María José Gómez-Cuesta,1 Enrique Cervantes-Bravo1,2

1 Clínica de la Fertilidad “CdelaF”, Ciudad de México.
2 Centro Médico ABC, Ciudad de México.


Corrrespondencia:

Jorge Rodríguez Purata
jorge@cdelaf.com

Debe citarse como:

Rodríguez-Purata J, Gómez-Cuesta MJ, Cervantes-Bravo E. ¿Fertilización in vitro o conversión a inseminación intrauterina en baja reserva? Revisión sistemática y metanálisis. Ginecol Obstet Mex. 2021; 89 (3): 232-246. https://doi.org/10.24245/gom.v89i3.4827

Resumen

OBJETIVO: Determinar si en pacientes con baja respuesta ovárica la continuación del procedimiento de fertilización in vitro se asocia con aumento de la tasa de nacidos vivos versus la conversión a inseminación intrauterina.

METODOLOGÍA: Búsqueda sistemática de estudios con reporte de tasa de nacidos vivos en las principales bases de datos. La evaluación de la calidad de los estudios se hizo con la puntuación de la escala Newcastle-Ottawa (NOS). Se realizó un análisis de subgrupos por respuesta folicular.

RESULTADOS: Se recuperaron 28 citas pero solo se analizaron 7 que incluían datos de 3398 pacientes-ciclos. La puntuación promedio de calidad NOS fue de 9 versus la conversión del ciclo en una inseminación intrauterina. Las mujeres con baja respuesta ovárica a la estimulación, durante un ciclo de fertilización in vitro, que continuaron con la recuperación de ovocitos y la transferencia de embriones tuvieron mayor probabilidad de un nacido vivo: 9.2% vs 3.7%. En el análisis por respuesta folicular, la fertilización in vitro fue superior, excepto cuando se observó una respuesta monofolicular: 3.6% con fertilización in vitro vs 2.7%.

CONCLUSIÓN: En pacientes con baja respuesta ovárica (≤ 4 folículos) durante un ciclo de fertilización in vitro, la persistencia con ésta se asoció con mayores probabilidades de lograr un nacido vivo versus la conversión a inseminación intrauterina, excepto en ciclos con una respuesta monofolicular, donde la conversión del ciclo en una inseminación intrauterina parece más juiciosa, en virtud de que las probabilidades de un nacido vivo son similares y no se necesitan procedimientos quirúrgicos ni de anestesia.

PALABRAS CLAVE: Infertilidad; fertilización in vitro; nacido vivo; tasa de nacimiento; transferencia de embriones.

Abstract

OBJECTIVE: To determine whether in patients with low ovarian response the continuation of the in vitro fertilization procedure is associated with increased live birth rates versus conversion to intrauterine insemination.

METHODOLOGY: Systematic search of studies with reported live birth rates in major databases. Quality assessment of studies was done using the Newcastle-Ottawa Scale (NOS) score. Subgroup analysis by follicular response was performed.

RESULTS: Twenty-eight citations were retrieved from which 18 were chosen and only 7 including data from 3398 patient-cycles (in vitro fertilization: 2115; IUI: 1283) were analyzed. The mean NOS quality score was 9 versus cycle conversion to intrauterine insemination. Women with low ovarian response to stimulation, during an in vitro fertilization cycle, who continued with oocyte retrieval and embryo transfer were more likely to have a live birth: 9.2% versus 3.7% (OR 3.15 (95%CI: 2.26-4.41)). In analysis by follicular response, in vitro fertilization was superior, except when a monofollicular response was observed: 3.6% with in vitro fertilization vs 2.7% (OR 1.02 (95%CI: 0.37-2.84)).

CONCLUSION: In patients with low ovarian response (≤ 4 follicles) during an in vitro fertilization cycle, persistence with in vitro fertilization is associated with higher odds of achieving a live birth versus conversion to intrauterine insemination, except in cycles with a monofollicular response, where conversion of the cycle to intrauterine insemination seems more judicious, since the odds of a live birth are similar and no surgical procedures or anesthesia are needed.

KEYWORDS: Infertility; Fertilization in vitro; Live birth; Birth rate; Embryo transfer.

    1. The European IVF-monitoring Consortium (EIM), for the European Society of Human Reproduction and Embryology (ESHRE), Calhaz-Jorge C, et al. Assisted reproductive technology in Europe, 2013: results generated from European registers by ESHRE†. Hum Reprod. 2017; 32 (10): 1957-73. doi.10.1093/humrep/dex264.
    2. Macklon NS, Stouffer RL, Giudice LC, Fauser BCJM. The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization. Endocr Rev. 2006; 27 (2): 170-207. doi.10.1210/er.2005-0015.
    3. Oudendijk JF, Yarde F, Eijkemans MJC, Broekmans FJM, Broer SL. The poor responder in IVF: is the prognosis always poor?: a systematic review. Hum Reprod Update. 2012; 18 (1): 1-11. doi.10.1093/humupd/dmr037.
    4. Ferraretti AP, La Marca A, Fauser BCJM, et al. ESHRE consensus on the definition of “poor response” to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011; 26 (7): 1616-24. doi.10.1093/humrep/der092.
    5. Veleva Z, Järvelä IY, Nuojua-Huttunen S, Martikainen H, Tapanainen JS. An initial low response predicts poor outcome in in vitro fertilization/intracytoplasmic sperm injection despite improved ovarian response in consecutive cycles. Fertil Steril. 2005; 83 (5): 1384-90. doi.10.1016/j.fertnstert.2004.11.056.
    6. Maheshwari A, Stofberg L, Bhattacharya S. Effect of overweight and obesity on assisted reproductive technology--a systematic review. Hum Reprod Update. 2007; 13 (5): 433-44. doi.10.1093/humupd/dmm017.
    7. Simoni M, Nieschlag E, Gromoll J. Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction. Hum Reprod Update. 2002; 8 (5): 413-21. doi.10.1093/humupd/8.5.413.
    8. Galey-Fontaine J, Cédrin-Durnerin I, Chaïbi R, Massin N, Hugues J-N. Age and ovarian reserve are distinct predictive factors of cycle outcome in low responders. Reprod Biomed Online. 2005; 10 (1): 94-99. doi.10.1016/s1472-6483(10)60808-5.
    9. Saldeen P, Källen K, Sundström P. The probability of successful IVF outcome after poor ovarian response. Acta Obstet Gynecol Scand. 2007; 86 (4): 457-61. doi.10.1080/00016340701194948.
    10. Matorras R, Corcóstegui B, Mendoza R, et al. Converting an IVF cycle to IUI in low responders with at least 2 follicles. J Reprod Med. 2003; 48 (10): 789-91.
    11. Lashen H, Ledger W, Lopez-Bernal A, Barlow D. Poor responders to ovulation induction: is proceeding to in-vitro fertilization worthwhile? Hum Reprod Oxf Engl. 1999; 14 (4): 964-69. doi.10.1093/humrep/14.4.964.
    12. Abusheikha N, Lass A, Burnley A, Brinsden P. In vitro fertilization cycles converted to intrauterine insemination because of poor follicular response have low success rates. Fertil Steril. 2001; 75 (3): 634-35. doi.10.1016/s0015-0282(00)01739-8.
    13. Freour T, Dubourdieu S, Mirallie S, Langlois ML, Jean M, Barrière P. IVF conversion to IUI in poor responders: an observational study. Arch Gynecol Obstet. 2010; 282 (4): 445-49. doi.10.1007/s00404-010-1515-0.
    14. Wood S, Rahim R, Searle T, et al. Optimal treatment for poor responders to ovarian stimulation: does in vitro insemination offer any advantages to intrauterine insemination? Hum Fertil Camb Engl. 2003; 6 (1): 13-18. doi.10.1080/1464770312331368923.
    15. Fujii DT, Quesnell JL, Heitmann RJ. Conversion to IUI versus continuance with IVF in low responder patients: A systematic review. Eur J Obstet Gynecol Reprod Biol. 2018; 227: 35-40. doi.10.1016/j.ejogrb.2018.05.032.
    16. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009; 62 (10): 1006-12. doi.10.1016/j.jclinepi.2009.06.005.
    17. Schardt C, Adams MB, Owens T, Keitz S, Fontelo P. Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inform Decis Mak. 2007; 7: 16. doi.10.1186/1472-6947-7-16.
    18. Hartling L, Hamm M, Milne A, et al. Validity and Inter-Rater Reliability Testing of Quality Assessment Instruments. Agency for Healthcare Research and Quality (US); 2012. http://www.ncbi.nlm.nih.gov/books/NBK92293/.
    19. Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [webpage on the Internet]. Ottawa, ON: Ottawa Hospital Research Institute; 2011. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
    20. Committee on Standards for Systematic Reviews of Comparative Effectiveness Research, Board on Health Care Services, Institute of Medicine. Finding What Works in Health Care: Standards for Systematic Reviews. (Eden J, Levit L, Berg A, Morton S, eds.). National Academies Press; 2011: 13059. doi.10.17226/13059.
    21. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21 (11): 1539-58. doi.10.1002/sim.1186.
    22. Higgins JPT, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011; 343: d5928-d5928. doi.10.1136/bmj.d5928.
    23. Shahine LK, Lathi RB, Baker VL. Oocyte retrieval versus conversion to intrauterine insemination in patients with poor response to gonadotropin therapy. Fertil Steril. 2009; 92 (4): 1315-17. doi.10.1016/j.fertnstert.2009.03.059.
    24. Norian JM, Levens ED, Richter KS, Widra EA, Levy MJ. Conversion from assisted reproductive technology to intrauterine insemination in low responders: is it advantageous? Fertil Steril. 2010; 94 (6): 2073-77. doi.10.1016/j.fertnstert.2009.12.056.
    25. Nicopoullos JDM, Abdalla H. Poor response cycles: when should we cancel? Comparison of outcome between egg collection, intrauterine insemination conversion, and follow-up cycles after abandonment. Fertil Steril. 2011; 95 (1): 68-71. doi.10.1016/j.fertnstert.2010.05.030.
    26. Shohieb A, Mostafa M, El-Khayat W. Conversion of ICSI cycles to IUI in poor responders to controlled ovarian hyperstimulation. Middle East Fertil Soc J. 2012; 17 (1): 42-46. doi.10.1016/j.mefs.2011.07.005.
    27. Reichman DE, Gunnala V, Meyer L, et al. In vitro fertilization versus conversion to intrauterine insemination in the setting of three or fewer follicles: how should patients proceed when follicular response falls short of expectation? Fertil Steril. 2013; 100 (1): 94-99. doi.10.1016/j.fertnstert.2013.02.049.
    28. Quinquin M, Mialon O, Isnard V, et al. In vitro fertilization versus conversion to intrauterine insemination in Bologna-criteria poor responders: how to decide which option? Fertil Steril. 2014; 102 (6): 1596-601. doi.10.1016/j.fertnstert.2014.08.023.
    29. Elzeiny H, Garrett C, Toledo M, Stern K, McBain J, Baker HWG. A randomised controlled trial of intra-uterine insemination versus in vitro fertilization in patients with idiopathic or mild male infertility. Aust N Z J Obstet Gynaecol. 2014; 54 (2): 156-61. doi.10.1111/ajo.12168.

Comentarios